The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck
Abstract
Background: To determine the effect of treatment time‐related factors on outcome in patients treated with surgery and postoperative radiation therapy (RT) for locally advanced squamous cell carcinoma of head and neck (SCCHN) Methods: A retrospective review was performed on 208 consecutive patients treated from 1992 to 1997 with surgery and postoperative RT (≥55 Gy) for SCCHN. The treatment time factors considered were (1) interval from surgery to the start of RT; (2) RT duration; and (3) the total time from surgery to completion of RT (treatment package time). Treatment package time was dichotomized into short (≤100 days) vs long (>100 days) categories. Other variables considered were clinical and pathologic staging, margin status, RT dose, and tumor site. Patients were also divided into intermediate‐ and high‐risk groups on the basis of eligibility for RTOG 95‐01. Univariate (logrank) and multivariate analyses were performed. Results: Median follow‐up for surviving patients was 24 months. Actuarial 2‐year locoregional control (LRC) and survival rates were 82% and 71%, respectively. In univariate analysis, factors associated with higher locoregional failure were high‐risk group (p = .011), margin status (p = .038), pathologic stage (p = .035), clinical N stage (p = .006), package time (p = .013), and RT treatment time (p = .03). Package time was also a significant predictor of survival in univariate analysis (p = .021). The other two individual time factors, tumor factors, and RT dose were not significant. Both risk status and treatment package time were significant factors in a multivariate model of LRC. Conclusions: A total treatment package time of <100 days is associated with improved tumor control and survival. Every effort should be made to keep the time from surgery to the completion of postoperative RT to <100 days. © 2002 John Wiley & Sons, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Al-Sarraf, M., LeBlanc, M., Giri, P. G., Fu, K. K., Cooper, J., Vuong, T., Forastiere, A. A., Adams, G., Sakr, W. A., Schuller, D. E., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1310 · Cited by 2,222
Herskovic, A., Martz, K., Al-Sarraf, M., Leichman, L., Brindle, J., Vaitkevicius, V., Cooper, J., Byhardt, R., Davis, L., & Emami, B. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206113262403 · Cited by 2,108
The hazard of accelerated tumor clonogen repopulation during radiotherapy
Withers, H. R., Taylor, J. M. G., & Maciejewski, B. (1988) · Acta Oncologica · doi:10.3109/02841868809090333 · Cited by 1,601
Fu, K. K., Pajak, T. F., Trotti, A., Jones, C. U., Spencer, S. A., Phillips, T. L., Garden, A. S., Ridge, J. A., Cooper, J. S., & Ang, K. K. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)00663-5 · Cited by 1,357
Lefebvre, J.-L., Chevalier, D., Luboinski, B., Kirkpatrick, A., Collette, L., & Sahmoud, T. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.13.890 · Cited by 1,334
Brizel, D. M., Albers, M. E., Fisher, S. R., Scher, R. L., Richtsmeier, W. J., Hars, V., George, S. L., Huang, A. T., & Prosnitz, L. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806183382503 · Cited by 1,127
Calais, G., Alfonsi, M., Bardet, E., Sire, C., Germain, T., Bergerot, P., Rhein, B., Tortochaux, J., Oudinot, P., & Bertrand, P. (1999) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/91.24.2081 · Cited by 1,060
Peters, L. J., Goepfert, H., Ang, K. K., Byers, R. M., Maor, M. H., Guillamondegui, O., Morrison, W. H., Weber, R. S., Garden, A. S., Frankenthaler, R. A., et al. (1993) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(93)90167-t · Cited by 538
Self-citationBachaud, J.-M., Cohen-Jonathan, E., Alzieu, C., David, J.-M., Serrano, E., & Daly-Schveitzer, N. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00430-0 · Cited by 328
Robertson, C., Robertson, A. G., Hendry, J. H., Roberts, S. A., Slevin, N. J., Duncan, W. B., MacDougall, R. H., Kerr, G. R., O'Sullivan, B., & Keane, T. J. (1998) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00716-5 · Cited by 154
Peters, L. J., & Withers, H. R. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(97)00466-5 · Cited by 125
Radiobiological considerations in the design of clinical trials
Bentzen, S. M. (1994) · Radiotherapy and Oncology · doi:10.1016/0167-8140(94)90443-x · Cited by 109
den Bogaert, W. F. V., van der Leest, A. H. D., Rijnders, A., Delaere, P., Thames, H. D., & van der Schueren, E. (1995) · Radiotherapy and Oncology · doi:10.1016/0167-8140(95)01597-a · Cited by 70
Cited by
Bernier, J., Cooper, J. S., Pajak, T. F., van Glabbeke, M., Bourhis, J., Forastiere, A., Ozsahin, E. M., Jacobs, J. R., Jassem, J., Ang, K.-K., et al. (2005) · Head & Neck · doi:10.1002/hed.20279 · Cited by 1,772
Oral Cavity Carcinoma: Current Management, Controversies, and Future Directions
Chinn, S. B., & Myers, J. N. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.2929 · Cited by 412
Graboyes, E. M., Kompelli, A. R., Neskey, D. M., Brennan, E., Nguyen, S., Sterba, K. R., Warren, G. W., Hughes-Halbert, C., Nussenbaum, B., & Day, T. A. (2019) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2018.2716 · Cited by 312
Karamboulas, C., Bruce, J. P., Hope, A. J., Meens, J., Huang, S. H., Erdmann, N., Hyatt, E., Pereira, K., Goldstein, D. P., Weinreb, I., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.10.004 · Cited by 94
Metadata
- Authors
- Rosenthal, D. I., Liu, L., Lee, J. H., Vapiwala, N., Chalian, A. A., Weinstein, G. S., Chilian, I., Weber, R. S., & Machtay, M.
- Venue
- Head & Neck
- Publisher
- Wiley
- Published
- 2002-02
- Volume
- 24
- Issue
- 2
- Pages
- 115-126
- ISSN
- 1043-3074 (ISSN-L)
- 1097-0347
- OpenAlex
- W2040549950
- Cited by
- 259
- References
- 15
- FWCI
- 6.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.